Market research
603139.SHG Shaanxi Kanghui Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- 20.05
- Dividend yield
- Not available
- Beta
- 0.56
Community
Investor discussion
1 comment
Sign in to join the 603139.SHG discussion.
5 years, 5 months ago
Shaanxi Kanghui Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 0.9% above its 200 day moving average.
From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Shaanxi Kanghui Pharmaceutical Co., Ltd's total revenue sank by 2.3% to $116M since the same quarter in the previous year.
Its net income has increased by 1.3% to $13M since the same quarter in the previous year.
Finally, its free cash flow fell by 201.7% to $-38M since the same quarter in the previous year.
Based on the above factors, Shaanxi Kanghui Pharmaceutical Co., Ltd gets an overall score of 3/5.